Lung Biotechnology Overview
- Year Founded
-
2006
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Lung Biotechnology General Information
Description
Developer of healthcare therapies designed to simplify and democratize the treatment of lung disease. The company's therapies seek to increase access and improve outcomes after lung transplantation for people with PAH and other fatal lung diseases, enabling patients to receive beneficial treatment for pulmonary diseases.
Contact Information
Website
www.lungbiotechnology.comCorporate Office
- 1040 Spring Street
- Silver Spring, MD 20910
- United States
Corporate Office
- 1040 Spring Street
- Silver Spring, MD 20910
- United States
Lung Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 03-Nov-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 01-Jan-2016 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 01-Jan-2015 | $10M | $10M | Completed | Generating Revenue |
Lung Biotechnology Patents
Lung Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024286647-A1 | A high resolution printing system and a method of aligning pixelated tiles | Pending | 06-Jun-2023 | ||
| EP-4724258-A1 | A high resolution printing system and a method of aligning pixelated tiles | Pending | 06-Jun-2023 | ||
| WO-2024254170-A1 | A high resolution printing system and a method of aligning pixelated tiles | Inactive | 06-Jun-2023 | ||
| US-20240408826-A1 | High resolution printing system and a method of aligning pixelated tiles | Pending | 06-Jun-2023 | ||
| AU-2024265057-A1 | Media composition for induced pluripotent stem cell derived endothelial cell growth, monolayer formation, and cell-cell contact formation | Pending | 03-May-2023 | C12N5/0696 |
Lung Biotechnology Investments (2)
Lung Biotechnology’s most recent deal was a Later Stage VC with TransMedics Group for . The deal was made on 11-Jul-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| TransMedics Group | 11-Jul-2016 | Later Stage VC | Other Devices and Supplies | ||
| Viridos | 06-May-2014 | Later Stage VC | Other Agriculture |
Lung Biotechnology FAQs
-
When was Lung Biotechnology founded?
Lung Biotechnology was founded in 2006.
-
Where is Lung Biotechnology headquartered?
Lung Biotechnology is headquartered in Silver Spring, MD.
-
What industry is Lung Biotechnology in?
Lung Biotechnology’s primary industry is Drug Discovery.
-
Is Lung Biotechnology a private or public company?
Lung Biotechnology is a Private company.
-
What is Lung Biotechnology’s current revenue?
The current revenue for Lung Biotechnology is .
-
How much funding has Lung Biotechnology raised over time?
Lung Biotechnology has raised $52M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process